Savvycom and Insider to Unlock the Full Story of APAC Enterprises’ Customer Data
HANOI, Vietnam, Aug. 2, 2022 /PRNewswire/ -- Savvycom, Vietnam's leading digital transformation and software development company, and Insider, a Unicorn Martech platform for individualized customer experiences, inked a strategic partnership combining Savvycom's in-depth technological knowledge in fintech, healthcare, and e-commerce with Insider's world-class customer analytics solutions to accelerate APAC enterprises' top-line growth. The Key Moment for a Successful Strategic Partnership This strategic partnership between two...
AVer Introduces Revolutionary Detachable Medical Grade Cameras
NEW TAIPEI CITY, Taiwan, Aug. 2, 2022 /PRNewswire/ -- AVer Information Inc., the award-winning provider of video collaboration and education technology solutions, is excited to introduce its Connected Health Solutions, which was created from AVer's dedication in understanding and contributing to the needs of the healthcare industry. Aiming to discover unmet...
Novel and fast typing method developed to control monkeypox by Molecular Biology Systems (MBS) in collaboration with the Amsterdam UMC and Danish Rigshospitalet
GOES, Netherlands, Aug. 2, 2022 /PRNewswire/ -- In the worldwide effort to control monkeypox, a novel and fast typing method to trace monkeypox virus strains was developed by Dutch company Molecular Biology Systems (MBS) in collaboration with the department of Medical Microbiology & Infectious Disease Prevention of the Amsterdam UMC and researchers of the Danish Rigshospitalet. Apart from being...
Kira Pharmaceuticals Appoints Angela Yan as President of China and Asia Development and Operations
CAMBRIDGE, Mass. and SUZHOU, China, Aug. 2, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced the appointment of Angela (Hui) Yan as President of China and Asia Development and Operations. In this role, Ms. Yan will lead Kira's China division,...
Telix APAC Report: Regulatory Progress for Prostate and Kidney Cancer Imaging
MELBOURNE, Australia, Aug. 2, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports on regulatory progress for the Company's core prostate and kidney cancer imaging programs in the Asia Pacific (APAC) Operating Region, including progress in the major market of China with its strategic partner Grand Pharmaceutical Group...
EXPERIENCES OF RACISM ASSOCIATED WITH POOR MEMORY, INCREASED COGNITIVE DECLINE
SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- Experiences of structural, interpersonal and institutional racism are associated with lower memory scores and worse cognition in midlife and old age, especially among Black individuals, according to studies reported today at the Alzheimer's Association International Conference® (AAIC®) 2022 in San Diego and virtually. Among the key...
“OpenDEL®3.0 – DRUG DISCOVERY PARTNER” webinar offered by HitGen and Endpoints News coming up on Thursday 4th August
CHENGDU, China, Aug. 1, 2022 /PRNewswire/ -- "OpenDEL®3.0 – DRUG DISCOVERY PARTNER" webinar will be jointly held by HitGen Inc. and Endpoints News on Thursday 4th August, to present you with a high-quality DEL product with all DEL information sharing and technical support. Dr. Guansai Liu, Executive Director of Discovery Chemistry Unit...
OriCell Therapeutics Raises Over $120 Million in Series B Financing Led by Qiming Venture Partners and Quan Capital to Advance Cell Therapies for Cancer Immunology
2022 is set to be a milestone year for OriCell who has been focusing on the field of cancer immunotherapy for more than seven years and is fully committed to becoming an innovative global drug developer. SHANGHAI, Aug. 1, 2022 /PRNewswire/ -- OriCell Therapeutics (Shanghai) Co., Ltd. ("OriCell" or "the Company") has announced the completion of Series...
Yunji’s Technology-empowered Private Label SUYE Celebrates Its 12th Anniversary
HANGZHOU, China, Aug. 1, 2022 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced the celebration of its private-label skin care brand SUYE's 12th anniversary. SUYE generated over 21 million RMB sales of its high-quality products during its anniversary month of July, including its newly launched GHK-Cu (Copper Glycyl-histidine-tripeptide)...
New Immunotherapy Combination Study for Nasopharyngeal Cancer Demonstrates Effectiveness of Lunit AI as Predictive Aid in Treatment Outcome–Published in Clinical Cancer Research
Recent clinical trial on combination immunotherapy for nasopharyngeal cancer provides evidence for Lunit SCOPE IO's ability to predict patient response. Analysis indicates Immune-excluded Immune Phenotype acts as a resistance mechanism against combination immunotherapy, further supporting Lunit SCOPE IO's ability to optimize cancer treatment selection. SEOUL, South Korea, Aug. 1, 2022...
